Clinical trials
Glomerulonephritis, IGA trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 8 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Alexion Pharmaceuticals, Inc. | 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 |
| ADARx Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Anthera Pharmaceuticals | 1 |
| Biogen | 1 |
| Calliditas Therapeutics AB | 1 |
| HI-Bio, A Biogen Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 27 |
| Glomerulonephritis | 9 |
| Kidney Diseases | 8 |
| Renal Insufficiency, Chronic | 8 |
| Proteinuria | 7 |
| Urologic Diseases | 6 |
| Autoimmune Diseases | 3 |
| Immune System Diseases | 3 |
| Nephritis | 3 |
| Lupus Nephritis | 2 |
Trials
Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.